chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a registered nurse refers to a 14 year old patient of unknown gender. The patient's relevant medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 13-SEP-2017, the patient was vaccinated with improperly stored VAQTA (dosing details were not reported) (lot # N008823, expiry date: 26-MAY-2018) and GARDASIL 9 (dosing details were not reported) (lot # N019923, expiry date: 28-APR-2019) for prophylaxis. No adverse effects were reported. Temperature excursion was from 0 degree Celsius (C) to 1 degree C (0.8 degree C) for 52 minutes. The previous temperature excursion was reported as from 9 degree C to 25 degree C (10.9 degree C) for 3 hours 17 minutes. The call was because of a data logger. No product quality complaint involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA007011: US-009507513-1709USA007012: US-009507513-1709USA007013: US-009507513-1709USA007014: US-009507513-1709USA000054.
Patient noted notable redness, tenderness and swelling 10/2/2020, and on 10/3/2020 noted swelling, stiffness, and pain along clavicle, neck on left shoulder with also some limited range of motion.  As of 10/08/2020 swelling, pain, and mobility were all notably improved.
Booster shot: Swelling of arm, armpit, and breast, headache . Fever, severe muscle aches, join pain, fever, abdominal cramps, diarrhea, increased Heart rate at rest 100-110, chest pressure  First 2 shots loss of period, fever muscle aches, headache, cough.
Patient received 2 doses of SinoVac in the past 03/18/2021 and 04/08/2021 - did not previously disclose this info in prior appointments of Pfizer. Patient received Pfizer 10/02/2021 and 10/23/2021.
Initial report received on 13 May 2009 from a physician. Subject identification number: 1-08-06459. This subject is participating in a study. A 14-year-old previously healthy male subject, who has concurrent medical condition of mild asthma, for which he uses XOPENEX on an as needed basis, had received on 30 November 2008 a dose of FLUZONE, lot number U2803AA. The route and site of administration was not reported. The subject presented with prolonged, generalized new onset of seizure and status epilepticus (onset date not reported) and was hospitalized from 30 November 2008 to 02 December 2008. There was no history of trauma, or substance abuse. Urine drug screen was negative. An MRI with/without contrast on 01 December 2008 revealed no intracranial abnormalities and with abnormal signal in the left middle ear cavity and mastoid region. An EEG was normal without epileptiform discharges. Cerebral spinal fluid Polymerase Chain Reaction was negative for enterovirus and herpes simplex virus. Blood culture was sterile. It was elected to observe the subject without anti-epileptic medication. The subject was discharged on hospital day three. The subject was re-admitted two days later from 04 December 2008 to 06 December 2008 for seizures (onset date not reported). The subject was loaded with fosphenytoin and ATIVAN. Urine drug screen was negative. Head CAT scan did not reveal hemorrhage or other intracranial pathology. A soft tissue density in the left mastoid was observed consistent with cholesteatoma. The subject was discharged home on hospital day three with KEPPRA 300 mg twice a day for prevention of seizures. The subject was re-admitted three days later from 09 December 2008 to 24 December 2008 for seizures (onset not reported). A lumbar puncture test was performed that revealing CSF protein of 50.9 mg/dL and glucose of 71mg/dL, both are within normal values. Urine drug screen was negative, repeat CAT scan of the head did not reveal any new findings, respiratory virus panel was negative and an EEG revealed marked slowing of the background consistent with persistent encephalopathy without accompanying seizure activity. A repeat EEG on 15 December 2008 revealed discharge events indicative of myoclonic seizures. The subject had an EKG that had ventricular tachycardia; however an echocardiogram of the heart was normal. Muscle and skin biopsy of the left thigh was performed to evaluate for progressive myoclonic epilepsy of the Lafora type; however, results of pathology test demonstrated no globules consistent with Lafora. Ophthalmologic examination was unremarkable. The subject was sent home on hospital day 16 on DEPAKOTE 1500 mg twice a day and rectal DIASTAT 17.5 mg for seizures lasting greater than five minutes. The subject's final diagnosis was new onset seizure, status epilepticus, myoclonic epilepsy. Recovery dates were not reported. Per the reporter, "none of the three serious adverse events were related to the he FLUZONE, and the SAEs not going to be reported to the IRB, or to VAERS." Documents held by sender: None.
within 10 minutes of receiving the dose my blood pressure skyrocketed, i was very weak, nauseous, dizzy, and sweating profusely. oxygen level was normal.  medical staff had me lie down for 30 minutes and drink water until blood pressure came down and i was okay to drive.
This case was reported by a healthcare professional and described the occurrence of itching in an adult female subject who was vaccinated with Engerix B for prophylaxis.  On 26 October 2006 the subject received 2nd dose of Engerix B in the right arm.  A few hours after receiving Engerix B, on 26 October 2006, the subject experienced itching on her neck, face and nose.  The subject received 50 mg diphenhydramine hydrochloride (Benadryl) the following day, on 27 October 2006, and the symptoms were relieved temporarily.  After a second, 50 mg dose of Benadryl taken 8 hours after the first, the event resolved.
4 to 5 inch raised hot Red hive. Itching inside my body. Arm throbbing pain off and on.  Headache,jaw ache.
Nausea and vomiting after receiving flu shot on 10-6-10 from afternoon until evening.
discoloration and itching at his SPV site.  Oct 08 he was seen for a pruritic erythmatous papule on rt upper chest that occurred post biopsy.  He was diagnosed as having a hypertropic scar.  He reported that he was treated by derm 7 months ago and it helped with the discoloration but it continues to itch.  Description of lesion, red, raised, smooth, within confines of his scar with itching.
High fever up to 103F with erythema and swelling of the arm that vaccines were given (left arm)- flu and Pneumovax. Self treated with Benadryl and was seen at facility 12/7/10 and was subsequently started on Keflex 500mg TID for 10 days for cellulitis.
Patient came to clinic to receive Influenza vaccine. Patient verified in record that last Influenza dose given was in 2020, making him due for flu shot. Patient stated he also went to the Health Dept the day before and they also told him he was due for a Influenza shot as it was not in his record. Vaccine administered. Upon documentation of vaccine in patient's chart, it was discovered that patient had received flu vaccine 11/3/21 at clinic with Dr.'s office. This vaccine never pulled over to records. Therefore, patient received 2 influenza vaccines in one season.
Per client 2 days after receiving vaccine on left deltoid, had rash on right arm, abdomen and left axilla extending down. Per client rash lasted 3 weeks and resolved on its own.
Took a COVID-19 test on 7/1 and went to the urgent care the same day and received Paxlovid.  My symptoms were very light and just had one night of high fever and felt better the next day other than fatigue.
Labrynthitis diagnosed after second vacc.(8/10)Was seen by PCP on 7/29/09 for general malaise, dizziness, nausea.  Seen also on 8/10, 8/19&20 for Hypotension, altered mentation, eye sensitivity.  Seen in the ER on 8/7/09 and the Urgent care on 8/13/09. Vaccination dates: #1 6/30/09, #2 8/3/09.  Did not relate any symptoms of problems at the time of the second vaccination.
vasovagal syncope bleeding at injection site nausea excessive thirst lightheadedness sweating feeling faint sense of doom tunnel hearing
Information has been received from a certificated medical assistant concerning a 73 year old female patient. On 09-MAR-2015 the patient was vaccinated with a 0.5 ml dose of PNEUMOVAX 23 (route and lot# not reported). On 09-MAR-2015, the patient complained of pain at injection site. The patient visited the unspecified physician's office on 12-MAR-2015 for the pain. There was no redness, swelling or warmth at the injection site. The patient was advised to taken TYLENOL and put ice packs on the site as needed. At the time of reporting, the patient stated that the site of injection was still very painful. Additional information has been requested.
dizziness; hallucinations; disorientation; fever/she had fever again; pain in the arm/pain in left arm; loose appetite/without appetite; forgetting things and words; could not even put up a sentence; difficulty breathing; needed help to walk; needed help to get dressed and eat due to hands tremor issue; vomiting; pneumonia; stopped eating; she was always tired; sleepy; stiffness in extremities; oxygen was low; she was not responsive/following instructions; This is a spontaneous report from a contactable consumer reporting for herself. An 82-year-old female patient (not pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 14Feb2021 08:45 on Left arm at single dose for COVID-19 immunization. Medical history included Hypertension. Concomitant medications included acetylsalicylic acid (ASPIRIN PROTEC), atorvastatin, losartan. The day of the vaccine administration she had fever and pain in the arm on 14Feb2021 20:00, next day on 15Feb2021 started with dizziness, hallucinations, disorientation. As the days went on in 2021, she started to loose appetite, forgetting things and words, she could not even put up a sentence but most importantly she had difficulty breathing, needed help to walk, get dressed and eat due to hands tremor issue. Afterwards; she had fever, vomiting, pneumonia and stopped eating, she is always tired, sleepy, with stiffness in extremities and pain in left arm. She was 1 day hospitalized and we had to bring her back to hospital because her oxygen was low, she had fever again, without appetite and she was not responsive/following instructions. All events were resulted in Emergency Room Visit and Physician Office Visit, Hospitalization for 1 day. Treatment received for the events included Oxygen, fluids, antibiotics. Lab data also included covid test type post vaccination=Nasal Swab on 01Mar2021 with Negative result. The outcome of the events were not resolved. Information on the lot/batch number has been requested.
Headache, NauseaVomiting nausea, fatigue, brain fog, headache Narrative: Advised symptomatic management and follow-up with PCP as needed.
short periods of dizziness when moving from horizontal to vertical or from lying on one side to the other side.
This spontaneous report as received from a other health professional refers to a female patient of unknown age. On an unknown date the patient was vaccinated with GARDASIL 9 lot # N009173 intramuscular for prophylaxis. On an unknown date the patient experienced inappropriate schedule of drug administration, no adverse event and product quality issue. Additional information has been requested.
EXTREMELY ITCHY EYES; BLURRED VISION; This spontaneous report received from a patient concerned a 60 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 04-JUN-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 04-JUN-2021, the subject experienced extremely itchy eyes. On 04-JUN-2021, the subject experienced blurred vision. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from extremely itchy eyes, and blurred vision. This report was non-serious.
bottom had rash and was itchy; Itchy; Fatigue; Ached all over; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (bottom had rash and was itchy), PRURITUS (Itchy), FATIGUE (Fatigue) and MYALGIA (Ached all over) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced RASH PRURITIC (bottom had rash and was itchy), PRURITUS (Itchy), FATIGUE (Fatigue) and MYALGIA (Ached all over). At the time of the report, RASH PRURITIC (bottom had rash and was itchy), PRURITUS (Itchy), FATIGUE (Fatigue) and MYALGIA (Ached all over) outcome was unknown. Not Provided          No concomitant medication was reported. No treatment medication was reported. Action taken with mRNA-1273 with respect to events was not applicable.
I had SOB return. It had gone away for months. I had not dealt with this until late September. I had to use my inhaler.  I went to my doctor about this. He changed my inhaler.
no adverse event; One dose of ROTATEQ was administered to patient outside of maximum age for first dose.; This spontaneous report was received from a nurse concerning a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On 27-JUN-2019, one dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot # R034878, expiration 11-SEP-2020 for prophylaxis (dose and route of administration was not reported) was administered to the patient, who was outside of maximum age for first dose (product administered to patient of inappropriate age).    No adverse effects reported. The outcome of product administered to patient of inappropriate age was not reported.
slight toungue and lip swelling  similar but not as bad as her allergic reaction to sulfa drugs.  along with rapid heart rate and difficulty walking.  next day she broke out with canker sores.
The patient developed chicken pox rash, a headache and a fever of 103F. The patient has 50 or more lesions.
Rash under arms and on chest.  Flu like symptoms.  Went to Health Services and they treated with OTC cold and flu medicine and cortisone.
The day after receiving his 2nd dose of the pfizer vaccine, he developed hemoptysis and R sided chest pain. He came to the ER on 4/21/21 and was found to have extensive bilateral pulmonary embolism with hemorrhage to likely the RML/RLL. He remained hemodynamically stable and did not require supplemental oxygen. He was started on heparin gtt with stable hemoglobin.
Pt. describes her arm as being "extremely sore" for three days. Approximately 8 hours after the vaccination, she experienced nausea, chills, and went to bed at 7:15, and woke up feeling "better", with the exception of the arm soreness.
coughing, wheezing, hives, dyspnea occured at 12 noon. tourniquet applied when patient had first cough and saw first hive on arm. injected epinephrine 0.1 cc into right arm above tourniquet. injected 0.1 cc on other side (left side). benadryl injected (25 MG)into left arm. decadron injected into right arm. ems called during the first few seconds and arrived within a few minutes. pulse ox of 97 % and oxygen was started  to prevent any drop in saturations. albuterol given.  3/9/09 MR received for DOS 1/26-27/09 with D/C DX:  Anaphylactic reaction to MMR, Varivax. Stridor, swelling of entire body. Pt presented following immunizations where pt immediately developed urticarial rash, cough, stridor and increased WOB. Tx Benadryl, solumedrol, albuterol, zantac. Improved and d/c next day.
Injected flu vaccine into patients deltoid, pulled out needle pt started to bleed. While cleaning area and applying band aid a lump about the size of a nickel and raised c-4 cm came up on pts arm at site of injection. Pt stated it was very painful. Advised to apply ice and take Tylenol.
Encephalitis. Vasculitis. Autoimmune dysfunction. Guillain Barre type syndrome. Intractable pain syndrome.  Full body burning pain.  Ovarian cysts. Hormonal abnormalities. Traumatic brain.  All caused by HPV.
Patient felt dizzy and light headed, had patient lay down flat on the bench, gave her some water and blood pressure checked bp at the time is 99/55. No other medications were given. BP rechecked after 10 mins was 109/56. Observed for addition 10 mins, patient stated she feel much better, walked around and left.  Follow up call 2 days later patient stated that she was fine.
This spontaneous report as received from a nurse practitioner refers to a 1 year old male patient. None pertinent medical history, drug reactions or allergies were reported. On 27-AUG-2013, the patient was vaccinated with VARIVAX first dose, 0.5 ml, subcutaneous, lot # J001648, expiration date: 11-FEB-2015. None concomitant medication was reported. On 06-SEP-2013, 10 days after administration of VARIVAX, the patient developed a 102 Fahrenheit fever. On 18-SEP-2012, 22 days after vaccination, the patient developed a widespread, varicella-like rash with greater than 50 lesions. Some lesions were maculo-papular, and a few lesions were vesicular. The patient sought medical attention by attending an office visit and was treated with Tylenol and calamine lotion topically. On an unknown day in September 2013, isolates of the lesions were sent to the Center for Disease Control and Prevention (CDC) for investigation and the results were negative to varicella. On 25-SEP-2013, the patient was examines and the lesions were "scabbed over", on the same date the patient was reported as recovered. Causality was not reported. Additional information has been requested.
Redness; swelling; Itching; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness), SWELLING (swelling) and PRURITUS (Itching) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 007M20A) for COVID-19 vaccination.     Concurrent medical conditions included Sulfonamide allergy (Sulfa), Drug allergy (Codiene) and Penicillin allergy. Concomitant products included AZELASTINE for Allergy, DENOSUMAB (PROLIA) from 05-Jul-2020 to an unknown date and CALCIUM CITRATE, COLECALCIFEROL (CALCIUM CITRATE + D3) for Osteoporosis, MIRABEGRON (MYRBETRIQ) and CURCUMA LONGA (TURMERIC [CURCUMA LONGA]) from 20-Jul-2019 to an unknown date for an unknown indication.   On 12-Feb-2021 at 4:45 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021 at 9:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced ERYTHEMA (Redness), SWELLING (swelling) and PRURITUS (Itching). On 16-Mar-2021, ERYTHEMA (Redness), SWELLING (swelling) and PRURITUS (Itching) had resolved.            No treatment medication were reported.   This case was linked to MOD-2021-026610 (Patient Link).
Breakthrough case admission after three vaccines Moderna 1/26/21 Lot# 007M20A;  Moderna 2/26/21 Lot# 010A21A;  Moderna 11/1/21 Lot# 005C21A
awful taste in her mouth; pain in both arms; This spontaneous case was reported by a consumer and describes the occurrence of TASTE DISORDER (awful taste in her mouth) and PAIN IN EXTREMITY (pain in both arms) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, the patient experienced TASTE DISORDER (awful taste in her mouth) and PAIN IN EXTREMITY (pain in both arms). At the time of the report, TASTE DISORDER (awful taste in her mouth) and PAIN IN EXTREMITY (pain in both arms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medication information was reported.
Client had 5 inch diameter hard, hot, red, sore, raised swelling on arm where injection was given. She did not experience this with dose 1 or dose 2. She called her PCP, who advised her to report it. No medications taken. She put cold packs on 3x per day for 6 days. At day 6 it started to decrease in size, and by day 8 was gone completely.
Very swollen eyes, nasal congestion, itchy back, anus, inner ears.  Treated with 1 over the counter benedryl.  Went to the ER, treated with another benedryl and pepsid. Discharged with an epipen.  I have a history of exercise induced anaphylaxis
The day following my 2nd pfizer dose. I started to have headaches, body aches, chills, feverish feelings, frequent bowel movements, sleepiness, fatigue, and ringing in my ears. It's been 10 days now and my symptoms continue. I went to an urgent care on 4/4/21. Dr said it was the vaccine working. 4/8/21 I went to urgent care again. Dr said it was very strange that my symptoms continued. Took covid test and was negative. 4/8/21 night I decided to go to the hospital because the symptoms were not getting any better. ER Dr ran tests - X ray, urine test, blood work. Everything came back normal. Dr said my immune system was in overdrive.
Right sided pain down to legs. 102 degree fever, chills, nausea, vomiting, delirious, weak.
11/1/2023 3:00pm Right eye pain 11/2/2023 7:00am numbness right side of tongue 11/2/2023 3:00pm face weakness  11/3/2023 7:00am full paralysis right side of face 11/3/2023 9:00 ER diagnosis Bell's Palsy Treatment given 20ml of prednisolone once daily for 10 days, 5ml of Acyclovir 5 times a day for 10 days and over the counter eye drops
12/29/21   Patient arrived for (ovarian cancer therapy) with complaints of flu like symptoms, cough, and chills. Patient put on Covid/airborne precaution. Orders received to Defer patient for 1 week.
88 y/o female with history of Afib, CAD who p/w increased abd pain and confusion. Patient resides at facility. Son gives the history. He states that for the last few days she has been more confused with more back and lower abd pain. She has been having emesis x 2-3 days as well. No fevers that he knows of, last fall about 4 weeks ago, bumping her head when trying to get up off the toilet. Patient saw Dr. this morning and said heart looked okay but sent her to the ER due to the symptoms as above.  In the ER, patient in afib with RVR. Covid positive. CT chest/abd/pelv shows acute cholecystitis and splenomegaly. WBC 25, Bili 3.4, plt 103.  Admission is requested.  Discharge Diagnoses:   1. Rapid atrial fibrillation, Discharge, 02/09/2022  2. Cholecystitis, acute, Discharge, 02/09/2022  3. Nausea and vomiting, Discharge, 02/09/2022  4. COVID-19 virus infection, Discharge, 02/09/2022
A week after I got the vaccine I had a couple of hives on my left arm, one being on the injection site. Over the pasr 11 days the area affected with hives has grown and spread from my upper left arm to my left forearm. I don't have hives anywhere else on my body at this time, but I am concerned about them spreading.